SSGJ-706

DRUG3 trials

Sponsors

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., Shenyang Sunshine Pharmaceutical Co., LTD.

Conditions

Advanced Solid Tumors PatientsFirst-line Advanced NSCLC PatientsNon Small Cell Lung Cancer

Phase 1

Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors

Not yet recruitingNCT06533605

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.Advanced Solid Tumors Patients

Start: 2024-08-31End: 2025-08-31Target: 60Updated: 2024-08-01

Phase 2

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

RecruitingNCT07171606

Shenyang Sunshine Pharmaceutical Co., LTD.First-line Advanced NSCLC Patients

Start: 2025-10-24End: 2027-08-31Target: 240Updated: 2025-12-18

SPGL008 in Combination With SSGJ-706 ± Chemotherapy for Advanced Non-small Cell Lung Cancer

Not yet recruitingNCT07874984

Shenyang Sunshine Pharmaceutical Co., LTD.Non Small Cell Lung Cancer

Start: 2026-11-01End: 2029-11-01Target: 220Updated: 2026-10-15